LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems has signed an agreement with Tianjin Port Free Trade Zone Administrative Committee and Tianyi Holdings to develop a proton therapy center in the rapidly growing research and development hub, the Tianjin Airport Economic Area. The agreement was signed at the China International Import Expo.
Under the agreement, the three parties will partner to develop a state-of-the-art proton therapy center to bring advanced healthcare services to Tianjin and its surrounding areas. In addition to clinical services, the Tianjin center will also pursue research activities to advance proton therapy.
The Tianjin Airport Economic Area was founded in 2015 to be a free trade hub supporting research and development of next-generation life sciences, aerospace technologies, and high-tech manufacturing.
About Mevion Medical Systems
Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe and China. For more information, please visit www.mevion.com